Browse the evidence

Total sleep time and sleep efficiency are significantly modulated by the circadian phase, being highest when the scheduled sleep episode coincides with the falling and plateau phases of the core body temperature rhythm, and lowest when it coincides with the rising phase.

For the most consolidated sleep, schedule your main sleep block during the time when your body temperature is falling and at its lowest (typically late night/early morning). Avoid scheduling long sleep blocks when your body temperature is rising (late afternoon/early evening), as this leads to shorter, less efficient sleep.

Replacing dietary saturated fat with refined carbohydrates or sugars does not reduce cardiovascular disease risk and may be neutral or harmful.

Do not replace saturated fats with refined carbs or sugars if your goal is heart health. This substitution does not lower cardiovascular risk. Instead, replace saturated fats with unsaturated fats (polyunsaturated or monounsaturated).

Marine n-3 PUFAs (EPA/DHA) exert anti-inflammatory effects by inhibiting NF-kB activation, activating PPAR-gamma, and binding to GPR120, leading to reduced production of pro-inflammatory cytokines and eicosanoids.

This paper explains the biological 'how' behind Omega-3s: they change cell membrane composition and interact with specific receptors (GPR120, PPAR-gamma) to turn down inflammatory signaling (NF-kB). This is useful for understanding why they work, but does not dictate a specific dosing protocol for users.

Healthier diets cost more per calorie than unhealthy diets, creating a financial barrier that explains socioeconomic disparities in diet quality and health outcomes.

For individuals with limited budgets, prioritizing nutrient density per calorie is crucial. Focus on affordable nutrient-dense foods like beans, lentils, and seasonal vegetables, which may offer better nutritional value per dollar than processed alternatives, despite potentially higher upfront costs per unit weight.

Behavioral treatments for chronic diseases must undergo a structured, iterative pre-efficacy development process (ORBIT model) involving Phase I (Design) and Phase II (Preliminary Testing) to ensure clinical significance before large-scale efficacy trials.

If you are developing a health behavior intervention, do not skip to large-scale testing. Use the ORBIT model: Start with Phase I (Design) to define the problem and basic elements, then Phase Ib (Refine) to optimize components and delivery. Only move to Phase II (Preliminary Testing) when you have a fixed protocol that shows clinically significant change in a small sample. This iterative process ensures your final large-scale trial has a real chance of success.

Chronic low-grade inflammation in adipose tissue, driven by M1 macrophage infiltration and pro-inflammatory cytokine secretion (TNF-α, IL-1β, IL-6), directly causes insulin resistance and contributes to the pathogenesis of Type 2 Diabetes.

For obese individuals, reducing body fat is critical not just for weight loss, but to reduce the chronic inflammation in fat tissue that blocks insulin. This inflammation directly impairs how your body uses glucose, increasing the risk of Type 2 Diabetes. Weight loss interventions that reduce this inflammation can improve insulin sensitivity.

A low-fat dietary intervention significantly reduces LDL cholesterol, diastolic blood pressure, and Factor VIIc levels, but does not significantly affect HDL cholesterol, triglycerides, glucose, or insulin levels.

If you follow a low-fat diet, you can expect a modest drop in LDL cholesterol and blood pressure. However, do not expect significant improvements in HDL cholesterol, triglycerides, or blood sugar control from this dietary pattern alone.

Longitudinal assessment of modifiable health behaviors (smoking, alcohol, diet, physical activity) explains a substantially larger proportion of the mortality risk associated with low socioeconomic position than single baseline assessments.

If you are assessing long-term health risk, do not rely on a single snapshot of your lifestyle. Behaviors like diet, activity, and smoking change over time, and these changes significantly impact mortality risk, especially for those with lower socioeconomic resources. To accurately gauge risk, one must track how these behaviors evolve, as static assessments miss critical shifts that drive health outcomes.

Higher body mass index (BMI) causally leads to lower circulating 25-hydroxyvitamin D [25(OH)D] concentrations, primarily due to sequestration of vitamin D in adipose tissue.

If you have a higher BMI, your body stores more vitamin D in fat tissue, leaving less in your blood. This means standard vitamin D doses might not be enough for you. You likely need higher doses to reach healthy blood levels, and simply taking a standard supplement may not correct a deficiency if your weight is not addressed.

Type 2 diabetes incidence in youth is increasing rapidly and is strongly associated with obesity, particularly in minority populations (Native American, African-American, Mexican-American, Japanese).

If you are a parent of a child in a high-risk ethnic group (Native American, African-American, Mexican-American, Japanese) and your child is overweight, discuss Type 2 diabetes screening with their doctor, even if they are young. The risk is real and increasing.

Testosterone administration in eugonadal men causes a dose-dependent decrease in HDL cholesterol and an increase in hemoglobin, while having no significant effect on PSA, sexual function, or spatial cognition at the doses studied.

Higher doses of testosterone will lower your 'good' cholesterol (HDL) and raise your hemoglobin. While PSA and sexual function remain stable, the cardiovascular risk profile changes with dose. Lower doses (125mg) may offer a better balance of muscle gain vs. lipid impact than the highest doses (600mg).

In a general population, 1 g/day marine n-3 supplementation significantly reduces the risk of total myocardial infarction.

While fish oil didn't prevent all heart issues, it did significantly lower the risk of heart attacks in this study. It may be worth discussing with your doctor, especially if you have other risk factors.

Obesity is a major risk factor for cancer, accounting for approximately 20% of all malignancies, with the strongest evidence linking it to endometrial, esophageal adenocarcinoma, colorectal, postmenopausal breast, prostate, and renal cancers.

Maintain a healthy body weight through diet and physical activity, as excess adiposity is a proven driver for several common cancers. Focus on reducing visceral fat, as abdominal obesity is strongly linked to higher cancer mortality.

Obesity increases the risk of postmenopausal estrogen receptor-positive (ER+) breast cancer and is associated with worse disease outcomes and higher mortality across all breast cancer subtypes.

For postmenopausal women, maintaining a healthy weight is critical to reducing the risk of developing estrogen-receptor-positive breast cancer and improving survival rates if diagnosed. This is achieved through lifestyle interventions that lower circulating estrogens and inflammatory markers.

Replacing animal-source foods with plant-based foods in high-income countries reduces greenhouse gas emissions by up to 84% and premature mortality by up to 12%, but may increase freshwater use by up to 16%.

In high-income countries, reducing your intake of animal-source foods and replacing them with plant-based options (especially legumes, fruits, and vegetables) can significantly lower your carbon footprint and improve your health. Be aware that this might increase your water usage, so choosing water-efficient plant foods can help mitigate this. This strategy is most effective where current meat consumption is high.

Prevention of obesity starting in childhood is critical and can have lifelong, perhaps multigenerational, impact, as fetal origins of obesity suggest that early life interventions are necessary to break the cycle of obesity and metabolic disease.

Focus on healthy eating and physical activity for children, especially those born small. This is the most effective way to prevent the lifelong health consequences of obesity and break the cycle of metabolic disease for future generations.

Muscle hypertrophy is driven by the PI3K-AKT-mTOR pathway, where IGF-1 and insulin signaling promote protein synthesis and inhibit degradation, while myostatin/activin signaling via Smad2/3 inhibits growth.

To build muscle, your body relies on specific hormonal signals like IGF-1 and insulin to activate the mTOR pathway, which drives protein synthesis and blocks breakdown. Conversely, myostatin acts as a brake on growth. Understanding this balance explains why resistance training (which stimulates these pathways) is effective, while conditions that elevate myostatin or impair insulin signaling can hinder growth.

Adherence to a Mediterranean diet supplemented with extra-virgin olive oil (1 L/week) or mixed nuts (30 g/day) slows age-related cognitive decline in older adults at high cardiovascular risk compared to a low-fat control diet.

To support cognitive health as you age, adopt a Mediterranean dietary pattern enriched with specific healthy fats. Specifically, aim for approximately 1 liter of extra-virgin olive oil per week and 30 grams of mixed nuts (walnuts, hazelnuts, almonds) daily. This approach has been shown in a major clinical trial to slow cognitive decline in older adults at high cardiovascular risk, outperforming standard low-fat dietary advice.

Central fat distribution (waist-to-hip ratio) is independently associated with insulin hypersecretion, particularly in women, but is not related to insulin sensitivity after adjusting for BMI.

For women, carrying weight around the waist is linked to higher insulin production, even if your blood sugar regulation (sensitivity) is normal. This suggests that central obesity drives hormonal demand. Weight loss strategies that reduce waist circumference may help lower insulin levels, but the primary driver of metabolic health in obesity appears to be the total amount of insulin secreted, not just where the fat is stored.

Serum 25-hydroxyvitamin D [25(OH)D] is the superior biomarker for assessing Vitamin D status compared to calcitriol, as it reflects both sun exposure and dietary intake and correlates better with physiological outcomes like calcium absorption.

When getting your Vitamin D checked, ensure your doctor orders '25-hydroxyvitamin D' (25(OH)D), not 'calcitriol' or '1,25-dihydroxyvitamin D'. The latter is not a reliable indicator of your body's Vitamin D stores and can be misleading.

High body mass index (BMI ≥ 25 kg/m²) is a major global cause of disease burden, contributing to 2.4 million deaths and 70.7 million disability-adjusted life years (DALYs) in females and 2.3 million deaths and 77.0 million DALYs in males in 2017, with cardiovascular disease, diabetes, and kidney diseases being the leading causes.

Maintaining a BMI within the healthy range (typically 18.5–24.9 kg/m²) is critical for preventing cardiovascular disease, diabetes, and kidney disease. Public health initiatives should target population-wide strategies to reduce high BMI, tailored to the development status of specific regions.

High BMI is the leading cause of disability-adjusted life years (DALYs) for cardiovascular disease, diabetes, and kidney diseases, accounting for 89.3% of all high-BMI-related DALYs.

Focusing on weight management is the most effective way to reduce the risk of heart disease, stroke, diabetes, and kidney disease, as these conditions are the primary drivers of health loss associated with high BMI.

Elevated levels of triglyceride-rich lipoproteins (TRL) and their remnants are causally associated with an increased risk of atherosclerotic cardiovascular disease (ASCVD), including myocardial infarction, ischemic stroke, and aortic valve stenosis, independent of LDL cholesterol levels.

High triglycerides are not just a number; they represent particles that directly contribute to heart disease. If your triglycerides are consistently above 1.2 mmol/L (100 mg/dL), you have elevated cardiovascular risk, even if your LDL is normal. Managing this involves dietary changes to reduce carbohydrate and alcohol intake, and potentially medication if lifestyle changes are insufficient, especially if you have diabetes or existing heart disease.

Apolipoprotein CIII (apoCIII) acts as a key inhibitor of lipoprotein lipase (LpL), and its reduction leads to more efficient clearance of triglycerides from the blood, thereby lowering plasma triglyceride levels and potentially reducing cardiovascular risk.

High levels of apoCIII slow down the breakdown of fat particles in your blood. This is often driven by insulin resistance. Managing insulin sensitivity through diet and exercise can naturally lower apoCIII levels, helping your body clear triglycerides more efficiently.